Ionis Pharmaceuticals, Inc. Amortization of Intangible Assets
Ionis Pharmaceuticals, Inc. (IONS) reported Amortization of Intangible Assets of $1.36 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2026-07-29
- Ionis Pharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2026-06-30 was $700.00K, a 17.06% increase year-over-year.
- Ionis Pharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2026-03-31 was $661.00K, a 13.57% increase year-over-year.
- Ionis Pharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2025-12-31 was $638.00K, a 39.00% increase year-over-year.
- Ionis Pharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2025-09-30 was $621.00K, a 0.65% increase year-over-year.
- Ionis Pharmaceuticals, Inc. amortization of intangible assets for fiscal 2025 was $2.44M, a 4.41% increase from fiscal 2024.
- Ionis Pharmaceuticals, Inc. amortization of intangible assets for fiscal 2024 was $2.34M, a 8.71% decline from fiscal 2023.
- Ionis Pharmaceuticals, Inc. amortization of intangible assets for fiscal 2023 was $2.56M, a 5.96% increase from fiscal 2022.
- Ionis Pharmaceuticals, Inc. amortization of intangible assets for fiscal 2022 was $2.42M, a 2.68% increase from fiscal 2021.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.36M 10-Q · filed 2026-07-29 | $2.00M derived: sum of 3 quarters · filed 2026-07-29 | $2.62M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $661.00K 10-Q · filed 2026-04-29 | $1.30M derived: sum of 2 quarters · filed 2026-04-29 | $1.92M derived: sum of 3 quarters · filed 2026-04-29 | $2.52M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $638.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.26M derived: sum of 2 quarters · filed 2026-02-26 | $1.86M derived: sum of 3 quarters · filed 2026-07-29 | $2.44M 10-K · filed 2026-02-26 |
| 2025-09-30 | $621.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.22M derived: sum of 2 quarters · filed 2026-07-29 | $1.80M 10-Q · filed 2025-10-29 | $2.26M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $598.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $1.18M 10-Q · filed 2026-07-29 | $1.64M derived: sum of 3 quarters · filed 2026-07-29 | $2.26M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $582.00K 10-Q · filed 2026-04-29 | $1.04M derived: sum of 2 quarters · filed 2026-04-29 | $1.66M derived: sum of 3 quarters · filed 2026-04-29 | $2.28M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.08M derived: sum of 2 quarters · filed 2026-02-26 | $1.70M derived: sum of 3 quarters · filed 2026-02-26 | $2.34M 10-K · filed 2026-02-26 |
| 2024-09-30 | $617.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.24M derived: sum of 2 quarters · filed 2025-10-29 | $1.88M 10-Q · filed 2025-10-29 | $2.53M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $621.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $1.26M 10-Q · filed 2025-07-30 | $1.92M derived: sum of 3 quarters · filed 2026-02-26 | $2.58M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $639.00K 10-Q · filed 2025-04-30 | $1.29M derived: sum of 2 quarters · filed 2026-02-26 | $1.95M derived: sum of 3 quarters · filed 2026-02-26 | $2.59M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $655.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.31M derived: sum of 2 quarters · filed 2026-02-26 | $1.95M derived: sum of 3 quarters · filed 2026-02-26 | $2.56M 10-K · filed 2026-02-26 |
| 2023-09-30 | $660.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.30M derived: sum of 2 quarters · filed 2024-11-06 | $1.90M 10-Q · filed 2024-11-06 | $2.51M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-06-30 | $637.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $1.24M 10-Q · filed 2024-08-01 | $1.85M derived: sum of 3 quarters · filed 2025-02-19 | $2.46M derived: sum of 4 quarters · filed 2025-02-19 |
| 2023-03-31 | $607.00K 10-Q · filed 2024-05-07 | $1.22M derived: sum of 2 quarters · filed 2025-02-19 | $1.82M derived: sum of 3 quarters · filed 2025-02-19 | $2.43M derived: sum of 4 quarters · filed 2025-02-19 |
| 2022-12-31 | $610.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | $1.22M derived: sum of 2 quarters · filed 2025-02-19 | $1.82M derived: sum of 3 quarters · filed 2025-02-19 | $2.42M 10-K · filed 2025-02-19 |
| 2022-09-30 | $608.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.21M derived: sum of 2 quarters · filed 2023-11-02 | $1.80M 10-Q · filed 2023-11-02 | $2.42M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-06-30 | $605.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.20M 10-Q · filed 2023-08-09 | $1.81M derived: sum of 3 quarters · filed 2024-02-21 | $2.41M derived: sum of 4 quarters · filed 2024-02-21 |
| 2022-03-31 | $592.00K 10-Q · filed 2023-05-03 | $1.20M derived: sum of 2 quarters · filed 2024-02-21 | $1.81M derived: sum of 3 quarters · filed 2024-02-21 | $2.40M derived: sum of 4 quarters · filed 2024-02-21 |
| 2021-12-31 | $612.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $1.22M derived: sum of 2 quarters · filed 2024-02-21 | $1.81M derived: sum of 3 quarters · filed 2024-02-21 | $2.35M 10-K · filed 2024-02-21 |
| 2021-09-30 | $603.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.20M derived: sum of 2 quarters · filed 2022-11-09 | $1.74M 10-Q · filed 2022-11-09 | $2.28M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $593.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.14M 10-Q · filed 2022-08-09 | $1.68M derived: sum of 3 quarters · filed 2023-02-22 | $2.20M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $544.00K 10-Q · filed 2022-05-04 | $1.08M derived: sum of 2 quarters · filed 2023-02-22 | $1.61M derived: sum of 3 quarters · filed 2023-02-22 | $2.12M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $538.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $1.06M derived: sum of 2 quarters · filed 2023-02-22 | $1.58M derived: sum of 3 quarters · filed 2023-02-22 | $2.06M 10-K · filed 2023-02-22 |
| 2020-09-30 | $527.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $1.04M derived: sum of 2 quarters · filed 2021-11-03 | $1.53M 10-Q · filed 2021-11-03 | $2.30M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $513.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $999.00K 10-Q · filed 2021-08-04 | $1.77M derived: sum of 3 quarters · filed 2022-02-25 | $1.96M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $486.00K 10-Q · filed 2021-05-05 | $1.26M derived: sum of 2 quarters · filed 2022-02-25 | $1.45M derived: sum of 3 quarters · filed 2022-02-25 | $1.93M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $773.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $964.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.44M derived: sum of 3 quarters · filed 2022-02-25 | $1.91M 10-K · filed 2022-02-25 |
| 2019-09-30 | $191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $669.00K derived: sum of 2 quarters · filed 2020-11-04 | $1.14M 10-Q · filed 2020-11-04 | $1.60M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $478.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $948.00K 10-Q · filed 2020-08-05 | $1.41M derived: sum of 3 quarters · filed 2021-02-24 | $1.88M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $470.00K 10-Q · filed 2020-05-06 | $936.00K derived: sum of 2 quarters · filed 2021-02-24 | $1.40M derived: sum of 3 quarters · filed 2021-02-24 | $1.85M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $466.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $927.00K derived: sum of 2 quarters · filed 2021-02-24 | $1.38M derived: sum of 3 quarters · filed 2021-02-24 | $1.82M 10-K · filed 2021-02-24 |
| 2018-09-30 | $461.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $913.00K derived: sum of 2 quarters · filed 2019-11-06 | $1.36M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $452.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $895.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $443.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $1.64M 10-K · filed 2020-03-02 | |||
| 2016-12-31 | $1.55M 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |